Organization: Health Canada
Year: 2023
Month: July
Request Number: A-2022-001654
Request Summary: Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate which was accepted into review on or after December 1, 2022. Please provide the name of the company (sponsor) who submitted this ANDS.
Disposition: Disclosed in part
Number of pages: 1